Literature DB >> 26945455

Tumor acidity-sensitive linkage-bridged block copolymer for therapeutic siRNA delivery.

Cong-Fei Xu1, Hou-Bing Zhang1, Chun-Yang Sun2, Yang Liu2, Song Shen2, Xian-Zhu Yang3, Yan-Hua Zhu2, Jun Wang4.   

Abstract

The design of ideal nanoparticle delivery systems should be capable of meeting the requirements of several stages of drug delivery, including prolonged circulation, enhanced accumulation and penetration in the tumor, facilitated cellular internalization and rapid release of the active drug in the tumor cells. However, among the current design strategies, meeting the requirements of one stage often conflicts with the other. Herein, a tumor pH-labile linkage-bridged block copolymer of poly(ethylene glycol) with poly(lacide-co-glycolide) (PEG-Dlinkm-PLGA) was used for siRNA delivery to fulfill all aforementioned requirements of these delivery stages. The obtained siRNA-encapsulating PEG-Dlinkm-PLGA nanoparticle gained efficiently prolonged circulation in the blood and preferential accumulation in tumor sites via the PEGylation. Furthermore, the PEG surface layer was detached in response to the tumor acidic microenvironment to facilitate cellular uptake, and the siRNA was rapidly released within tumor cells due to the hydrophobic PLGA layer. Hence, PEG-Dlinkm-PLGA nanoparticles met the requirements of several stages of drug delivery, and resulted in the enhanced therapeutic effect of the nanoparticular delivery systems.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cancer nanotechnology; PEG detachment; Tumor pH-responsive; siRNA

Mesh:

Substances:

Year:  2016        PMID: 26945455     DOI: 10.1016/j.biomaterials.2016.02.031

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  17 in total

Review 1.  PEGylation: a promising strategy to overcome challenges to cancer-targeted nanomedicines: a review of challenges to clinical transition and promising resolution.

Authors:  Zahid Hussain; Shahzeb Khan; Muhammad Imran; Muhammad Sohail; Syed Wadood Ali Shah; Marcel de Matas
Journal:  Drug Deliv Transl Res       Date:  2019-06       Impact factor: 4.617

Review 2.  Advances in Stimulus-Responsive Polymeric Materials for Systemic Delivery of Nucleic Acids.

Authors:  Minjie Sun; Kaikai Wang; David Oupický
Journal:  Adv Healthc Mater       Date:  2017-12-11       Impact factor: 9.933

Review 3.  Non-viral vectors for RNA delivery.

Authors:  Yi Yan; Xiao-Yu Liu; An Lu; Xiang-Yu Wang; Lin-Xia Jiang; Jian-Cheng Wang
Journal:  J Control Release       Date:  2022-01-10       Impact factor: 9.776

Review 4.  Nanoparticle-mediated co-delivery of chemotherapeutic agent and siRNA for combination cancer therapy.

Authors:  Bo Xiao; Lijun Ma; Didier Merlin
Journal:  Expert Opin Drug Deliv       Date:  2016-07-06       Impact factor: 6.648

5.  SiRNA Crosslinked Nanoparticles for the Treatment of Inflammation-induced Liver Injury.

Authors:  Yaqin Tang; Ziying Zeng; Xiao He; Tingting Wang; Xinghai Ning; Xuli Feng
Journal:  Adv Sci (Weinh)       Date:  2016-09-02       Impact factor: 16.806

Review 6.  Current Multistage Drug Delivery Systems Based on the Tumor Microenvironment.

Authors:  Binlong Chen; Wenbing Dai; Bing He; Hua Zhang; Xueqing Wang; Yiguang Wang; Qiang Zhang
Journal:  Theranostics       Date:  2017-01-07       Impact factor: 11.556

7.  Tumor Microenvironment Targeted Nanotherapy.

Authors:  Clara Fernandes; Divya Suares; Mayur C Yergeri
Journal:  Front Pharmacol       Date:  2018-10-31       Impact factor: 5.810

Review 8.  Nanomedicine applications in the treatment of breast cancer: current state of the art.

Authors:  Di Wu; Mengjie Si; Hui-Yi Xue; Ho-Lun Wong
Journal:  Int J Nanomedicine       Date:  2017-08-16

9.  Doxorubicin-conjugated pH-responsive gold nanorods for combined photothermal therapy and chemotherapy of cancer.

Authors:  Jin Chen; Xiao Li; Xinlian Zhao; QianQian Wu; Huihui Zhu; Zhengwei Mao; Changyou Gao
Journal:  Bioact Mater       Date:  2018-05-15

10.  Targeting of NLRP3 inflammasome with gene editing for the amelioration of inflammatory diseases.

Authors:  Congfei Xu; Zidong Lu; Yingli Luo; Yang Liu; Zhiting Cao; Song Shen; Hongjun Li; Jing Liu; Kaige Chen; Zhiyao Chen; Xianzhu Yang; Zhen Gu; Jun Wang
Journal:  Nat Commun       Date:  2018-10-05       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.